2022
DOI: 10.1177/02692163221101748
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the prevalence, impact and experience of cardiac cachexia in patients with advanced heart failure and their caregivers: A sequential phased study

Abstract: Background: Cardiac Cachexia is a wasting syndrome that has a significant impact on patient mortality and quality of life world-wide, although it is poorly understood in clinical practice. Aim: Identify the prevalence of cardiac cachexia in patients with advanced New York Heart Association (NYHA) functional class and explore its impact on patients and caregivers. Design: An exploratory cross-sectional study. The sequential approach had two phases, with phase 1 including 200 patients with NYHA III-IV heart fail… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 53 publications
1
3
0
Order By: Relevance
“…The hemoglobin counts in the cachectic groups were much lower, according to Mathew A. Carson et al (2022). Therefore, the current study is consistent with the earlier study.…”
Section: Resultssupporting
confidence: 91%
“…The hemoglobin counts in the cachectic groups were much lower, according to Mathew A. Carson et al (2022). Therefore, the current study is consistent with the earlier study.…”
Section: Resultssupporting
confidence: 91%
“… 23 Another potential explanation of our findings could be attributed to the association between being underweight, a surrogate of frailty, and the severity of cardiac dysfunction. This theory was validated in a cross-sectional study by Carson et al 24 They observed cardiac cachexia as a predominant finding in advanced heart failure patients with a poor functional status and high odds of mortality.…”
Section: Discussionmentioning
confidence: 75%
“… 15 For example, a 10.5% to 16% cachexia prevalence has been reported per >5% unintentional edema‐free weight loss criteria (n=238, mean age 71 years; n=11 712 clinical trial participants, mean age 65 years). 2 , 16 A recent study of 200 inpatients and outpatients with New York Heart Association class III–IV heart failure in the United Kingdom used consensus cachexia criteria incorporating weight loss, anthropometrics, strength, symptoms, and biochemistry, and found a 15% prevalence, 17 whereas a US analysis of heart failure inpatient diagnostic codes yielded 7% cachexia. 18 Rates ranging from 19.5% to 52% are reported using dual x‐ray absorptiometry appendicular lean mass criteria (n=200, mean age 70 years; n=38, mean age 75 years).…”
Section: Discussionmentioning
confidence: 99%